Orthofix Medical Inc

Healthcare · Medical Devices

9.20$ +1.9% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Income Statement

Orthofix Medical Inc (OFIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 211 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OFIX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	98	109	103	109	105	117	109	112	112	121	109	116	113	121	105	73	111	118	106	121	112	125	106	118	114	122	175	187	184	200	189	199	197	216	194	203	206	220	197	211	833
Cost of Revenue	20	23	23	23	24	24	24	23	24	26	24	26	25	26	23	23	26	29	26	27	28	33	28	32	31	33	65	67	64	64	61	64	62	67	72	64	57	78	57	61	253
Gross Profit	79	85	80	86	82	93	85	89	88	95	85	90	89	95	81	50	85	89	80	94	84	92	78	86	83	89	110	120	120	137	127	135	135	149	122	140	149	142	140	150	580
Research & Development	6.9	7.5	7.4	6.9	6.9	8.5	6.9	7.9	9.6	8.8	9.2	9.0	8.0	8.4	10.0	8.8	10.0	10	11	13	12	13	11	13	12	13	23	19	19	19	19	18	17	19	20	16	15	15	15	16	61
Selling, General & Administrative	19	21	18	20	18	19	19	22	23	20	20	22	21	22	18	15	17	18	16	18	16	18	19	16	19	25	49	34	27	35	32	34	34	433	133	136	148	137	135	138	558
Total Operating Expenses	67	77	74	78	72	80	77	82	82	83	83	88	84	91	75	71	81	85	83	90	84	101	81	80	89	100	170	156	144	155	157	160	154	160	170	156	166	129	153	158	605
Operating Income	9.3	7.4	5.9	8.0	9.0	18	7.9	7.0	3.9	12	-4.4	0.5	-19	4.1	6.9	-21	4.2	3.7	-2.9	4.3	-0.3	-9.4	-3.1	6.6	-5.8	-11	-60	-37	-24	-18	-29	-25	-19	-11	-49	-16	-17	13	-14	-8.1	-25
Interest Expense	0.5	0.4	0.0	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.3	0.5	0.2	0.5	0.4	0.9	0.7	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	1.3	1.3	1.6	4.5	4.6	4.9	5.2	15	4.5	4.0	4.7	4.4	5.7	6.1	21
Pre-Tax Income	9.1	3.7	1.6	8.7	9.5	17	11	2.0	-1.3	12	-5.1	0.7	-27	4.2	5.6	-17	5.3	5.6	-6.0	4.7	-2.5	-9.6	-4.4	3.0	-9.4	-7.0	-60	-38	-28	-22	-35	-32	-27	-30	-52	-14	-22	-2.2	-21	-15	-60
Income Tax Expense	-1.3	8.8	3.9	3.9	6.2	15	5.4	1.1	-0.1	2.7	-6.0	1.2	14	-7.5	-20	1.6	0.6	15	-0.2	2.2	-0.4	23	0.1	0.6	1.3	0.1	0.6	1.5	0.5	0.1	0.9	1.1	0.8	-0.6	1.0	-0.1	0.5	0.0	0.1	0.8	1.4
Net Income	9.9	-3.2	-2.7	3.9	3.5	1.6	5.2	0.9	-1.2	8.9	0.9	-0.5	-40	12	26	-18	4.7	-9.4	-5.8	2.4	-2.2	-33	-4.5	2.5	-11	-7.1	-61	-39	-29	-22	-36	-33	-27	-29	-53	-14	-23	-2.2	-21	-16	-62
EBITDA	12	7.9	11	13	14	21	15	6.6	11	18	1.6	9.4	12	5.2	13	-8.1	16	24	2.7	14	5.9	-0.9	4.3	11	-0.8	1.4	-45	-22	-13	-0.6	-14	-12	-4.6	13	-12	7.7	-3.1	92	-1.7	20	107

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings